Parag Mallick - Jun 9, 2021 Form 3 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Chief Scientist, Director, 10%+ Owner
Signature
/s/ Anna Mowry, as Attorney-in-Fact
Stock symbol
NAUT
Transactions as of
Jun 9, 2021
Transactions value $
$0
Form type
3
Date filed
6/9/2021, 09:41 PM
Next filing
Dec 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NAUT Common Stock 20.7M Jun 9, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAUT Stock Option (Right to Buy) Jun 9, 2021 Common Stock 464K $10.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the "Plan")) through each vesting date, one thirty-sixth (1/36th) of the shares subject to the Option shall vest each month over the thirty-six (36) months following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 31, 2021.

Remarks:

Exhibit 24: Power of Attorney